The healthcare sector will suffer the most if the federal Medicaid cuts proposed in Congress are enacted, the Commonwealth Fund said. According to the group’s analysis, hospitals, nursing homes, and clinics could be forced to shut their doors.

The legal case brought by all 50 states, Washington D.C., and multiple U.S. territories against Purdue Pharma and the Sackler family has come to an end, with settlement funds set to be used for addiction recovery.

American Medical Association President Bruce Scott, MD, has expressed major concerns about significant healthcare spending cuts proposed by the Trump administration. These include reductions to Medicaid, deep cuts to NIH funding, staffing reductions, and policy changes at key federal agencies.

Workers are returning to the Centers for Disease Control and Prevention, the National Institutes of Health and other departments. Kennedy said the reinstatements were necessary for the agencies to perform their duties.

An urgent device recall has been issued on Bravo CF, a line of pH capsules that are placed in the esophagus to aid in understanding the effects of acid reflux. Due to a dangerous manufacturing error, certain lots of the devices must be quarantined immediately.

A report from the Chartis Center for Rural Health warns that many hospitals in rural communities are at risk of closure if Medicaid cuts pass through Congress and are enacted by President Donald Trump. According to the analysis, women and newborns will disproportionately lose access to care. 

Among healthcare organizations sweating the possible passage of the “One Big Beautiful Bill,” few have more to worry about than nonprofit hospitals and health systems that compete with privately held or publicly traded rivals for executive talent.

Staff purged from the Department of Health and Human Services by Elon Musk's Department of Government Efficiency claim their termination notices contained bogus information and other inaccuracies that were cited as justifications for performance-based firings. The plaintiffs are seeking unspecified damages.

Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.

OSU Medical Center has addressed common challenges including insufficient documentation, miscommunication, and the risk of repeat imaging.